Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors
BusinessWire
April 7, 2025
Rajesh Ramaswamy: Teaching Machines to Generate Tomorrow’s Medicines
January 8, 2025
Hear from Sail’s SVP, Head of Machine Learning and Artificial Intelligence Strategy, Rajesh Ramaswamy, on how we are utilizing cutting-edge generative AI technology to engineer RNA medicine components: accelerating our knowledge and fueling the performance of our first wave of programs to develop tomorrow’s medicines, today.
Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board
Business Wire
April 2, 2024
Sail Biomedicines Appoints Kerry Benenato, Ph.D., as Chief Platform Officer
Business Wire
February 7, 2024
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Business Wire
January 5, 2024
Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board
Business Wire
January 4, 2024
Sail Biomedicines Receives Grants to Fight Malaria by Developing a New Class of RNA Medicines
Business Wire
January 3, 2024
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to form Sail Biomedicines
Flagship Pioneering
October 19, 2023